ShutaIshibeMD
Nephrology • New Haven, CTSection of Nephrology, Internal Medicine, Yale University School of Medicine
Dr. Ishibe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 York Street, Cb-2041
New Haven, CT 06510Phone+1 203-688-4748Fax+1 203-688-4740
Education & Training
Yale-New Haven Medical CenterFellowship, Nephrology, 2001 - 2005
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1997 - 2000
University of Texas Southwestern Medical SchoolClass of 1997
Certifications & Licensure
RI State Medical License 2024 - 2026
CT State Medical License 2004 - 2025
TX State Medical License 1998 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- CRB2 Depletion Induces YAP Signaling and Disrupts Mechanosensing in Podocytes.Yingyu Sun, Nils M Kronenberg, Sidharth K Sethi, Surjya N Dash, Maria E Kovalik
Biorxiv. 2024-10-26 - 1 citationsZFYVE21 promotes endothelial nitric oxide signaling and vascular barrier function in the kidney during aging.Quan Jiang, Guiyu Song, Liying He, Xue Li, Bo Jiang
Kidney International. 2024-09-01 - Preventing MMP23-mediated cleavage of podocyte RARRES1: a novel strategy to halt chronic kidney disease progression?Paulina X Medina Rangel, Shuta Ishibe
Kidney International. 2024-07-01
Press Mentions
SI Survey: Doctors Say They'd Play in the NBA and NHL, but Not NFL and MLBAugust 24th, 2020- New Urine Biomarker May Help Predict Diabetic Kidney DiseaseSeptember 3rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
